Pharmacodynamic Effects of Nitroimidazoles Alone and in Combination with Clarithromycin on Helicobacter pylori

Author:

Svensson Margareta12,Ström Magnus2,Nilsson Maud1,Sörberg Mikael3,Nilsson Lennart E.1

Affiliation:

1. Divisions of Clinical Microbiology

2. Gastroenterology, Department of Molecular and Clinical Medicine, Faculty of Health Sciences, SE-581 85 Linköping

3. Infectious Diseases Unit, Department of Medicine, Karolinska Hospital, S-171 76 Stockholm, Sweden

Abstract

ABSTRACT Pharmacodynamic studies of Helicobacter pylori exposed to metronidazole and tinidazole alone and in combination with clarithromycin were performed by bioluminescence assay of intracellular ATP. The pharmacodynamic parameter control-related effective regrowth time (CERT) was used. CERT is defined as the time required for the resumption of logarithmic growth and a return of the level of growth to the preexposure inoculum in the test culture minus the corresponding time in the control culture. CERT measures the combined effects of the initial level of killing and postantibiotic effect. The incubation times and drug concentrations were chosen according to their half-lives and their clinically achievable concentrations. The study shows that the parameter CERT is useful for the testing of antibiotic combinations. The CERTs induced by clarithromycin, metronidazole, and tinidazole alone and in the combinations tested were concentration dependent, with no maximum response, indicating that the use of high doses may be preferable. The combinations with the highest concentrations induced synergistic effects and prevented regrowth. The use of tinidazole in combination with clarithromycin proved to give the longest CERTs, indicating that this is the most effective combination.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference29 articles.

1. Bamba, H., Y. Kondo, R. M. Wong, S. Sekine, and F. Matsuzaki. 1997. Minimum inhibitory concentration of various single agents and the effect of their combinations against Helicobacter pylori, as estimated by a fast and simple in vitro assay method. Am. J. Gastroenterol.92:659-662.

2. Baquero, F., E. Culebras, C. Patron, J. C. Perez-Diaz, J. C. Medrano, and M. F. Vicente. 1986. Postantibiotic effect of imipenem on gram-positive and gram-negative micro-organisms. J. Antimicrob. Chemother.18(Suppl. E):47-59.

3. Bazzoli, F., R. M. Zagari, S. Fosssi, P. Pozzato, G. Alampi, P. Simoni, S. Sottili, A. Roda, and E. Roda. 1994. Short-term low-dose triple therapy for eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol.6:773-777.

4. Cederbrant, G., G. Kahlmeter, C. Schalen, and C. Kamme. 1994. Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori. J. Antimicrob. Chemother.34:1025-1029.

5. Chu, S., D. S. Wilson, R. L. Deaton, A. V. Mackenthun, C. N. Eason, and J. H. Cavanaugh. 1993. Single- and multiple-dose pharmacokinetics of clarithromycin, a new macrolide antimicrobial. J. Clin. Pharmacol.33:719-726.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3